Balance Sheet - Zenas BioPharma, Inc. (ZBIO)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 343.19 | 350.77 | 56.86 | 67.21 |
| Other current assets | 7.98 | 5.16 | 2.95 | 1.24 |
| Total current assets | 351.17 | 355.92 | 59.80 | 68.44 |
| Total non-current assets | 32.47 | 14.05 | 8.38 | 6.14 |
| Total assets | 383.64 | 369.97 | 68.18 | 74.58 |
| Total current liabilities | 62.65 | 57.29 | 23.26 | 25.97 |
| Total non-current liabilities | 78.85 | 0.22 | 270.64 | 240.90 |
| Total liabilities | 141.50 | 57.51 | 293.90 | 266.87 |
| Total stockholders' equity | 242.14 | 312.46 | -225.72 | -192.29 |
| Common shares outstanding | 45 | 42 | 38 | 38 |
Show Quarterly Balance Sheet
Balance Sheet - Zenas BioPharma, Inc. (ZBIO)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 717.21 | 343.19 | 290.88 | 273.28 | 312.38 | 350.77 | 386.80 | 183.93 | 37.15 | 56.86 | 72.31 | 0.00 | 67.21 | 67.21 |
| Accounts receivable, net | 1.10 | |||||||||||||
| Other current assets | 11.86 | 7.98 | 5.76 | 5.32 | 5.43 | 5.16 | 6.98 | 4.67 | 2.55 | 2.95 | 4.37 | 1.24 | ||
| Total current assets | 730.16 | 351.17 | 296.64 | 278.60 | 317.81 | 355.92 | 393.78 | 188.60 | 39.71 | 59.80 | 76.68 | 67.21 | 68.44 | |
| Total non-current assets | 17.52 | 32.47 | 25.38 | 14.48 | 15.96 | 14.05 | 9.65 | 11.35 | 9.35 | 8.38 | 7.12 | -67.21 | 6.14 | |
| Total assets | 747.68 | 383.64 | 322.02 | 293.09 | 333.77 | 369.97 | 403.43 | 199.95 | 49.05 | 68.18 | 83.79 | 74.58 | ||
| Total current liabilities | 61.16 | 62.65 | 52.42 | 53.24 | 49.13 | 57.29 | 44.00 | 39.11 | 30.33 | 23.26 | 15.56 | 25.97 | ||
| Total non-current liabilities | 350.69 | 78.85 | 73.17 | 0.22 | 0.32 | 0.22 | 0.00 | 0.01 | 271.21 | 270.64 | 270.47 | -47.80 | 240.90 | |
| Total liabilities | 411.85 | 141.50 | 125.59 | 53.46 | 49.45 | 57.51 | 44.00 | 39.12 | 301.55 | 293.90 | 286.02 | -47.80 | 266.87 | |
| Total stockholders' equity | 335.83 | 242.14 | 196.43 | 239.63 | 284.32 | 312.46 | 359.44 | 160.83 | -252.50 | -225.72 | -202.23 | 47.80 | -192.29 | |
| Common shares outstanding | 56 | 46 | 42 | 42 | 42 | 42 | 42 | 38 | 38 | 38 | 42 | 38 | 38 | 38 |